Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience <scp>measurable residual disease</scp> (MRD) recurrence following <scp>MRD</scp> ‐negative remission-Reference-Cited by-同舟云学术

Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD ‐negative remission

Published:2022-09-08 Issue:11 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Short Nicholas J.¹^ORCID,Macaron Walid¹^ORCID,Kadia Tapan¹^ORCID,Dinardo Courtney¹^ORCID,Issa Ghayas C.¹^ORCID,Daver Naval¹^ORCID,Wang Sa²,Jorgensen Jeff²,Nguyen Daniel³,Bidikian Aram¹,Patel Keyur P.²,Loghavi Sanam²^ORCID,Konopleva Marina¹^ORCID,Yilmaz Musa¹^ORCID,Jabbour Elias¹^ORCID,Maiti Abhishek¹^ORCID,Abbas Hussein A.¹^ORCID,Shpall Elizabeth⁴,Popat Uday⁴,Al‐Atrash Gheath⁴,Pierce Sherry¹,Kantarjian Hagop M.¹^ORCID,Ravandi Farhad¹^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of Medicine, McGovern Medical School The University of Texas Health Science Center at Houston Houston Texas USA

4. Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26698

Reference5 articles.

1. Acute myeloid leukaemia

2. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

3. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

4. Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

5. Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A chest CT-based nomogram for predicting survival in acute myeloid leukemia;BMC Cancer;2024-04-12

2. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions;Biomedicines;2024-03-07

3. How I treat refractory and relapsed acute myeloid leukemia;Blood;2024-01-04

4. Optimal Post-Remission Consolidation Therapy in Patients with AML;Acta Haematologica;2023-11-26

5. Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest;Cancers;2023-11-10